focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 781.60
Bid: 781.80
Ask: 782.20
Change: -4.20 (-0.53%)
Spread: 0.40 (0.051%)
Open: 784.20
High: 787.20
Low: 781.60
Prev. Close: 785.80
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on directors’ remuneration

17 Mar 2023 08:59

RNS Number : 3583T
Standard Chartered PLC
17 March 2023
 

Standard Chartered PLC

17 March 2023

 

Update on directors' remuneration

2020-22 Long-term incentive plan (LTIP) performance outcome

In the 2022 directors' remuneration report (DRR), Standard Chartered PLC (SC) disclosed details of the expected performance outcome for the 2020-22 LTIP awards which began to vest on 15 March 2023. This showed that the threshold Return on Tangible Equity (RoTE) target had not been achieved and that the Remuneration Committee had determined the vesting outcome for the strategic measures at 22 per cent (out of a maximum 33.3 per cent). It was also stated in the DRR that performance against the Total Shareholder Return (TSR) threshold target would be measured in March 2023 and that at the time of the DRR publication, it was not expected to be achieved.

Unlike the RoTE and strategic performance measures, which are assessed on a financial year timeframe, TSR is measured over the LTIP performance period which starts from the date of grant (i.e., 9 March 2020 for the 2020-22 LTIP) and ends on the day before the third anniversary of the grant date. Performance is assessed by calculating the change in TSR over the three-year performance period, based on the average over a month at the start and end of the performance period, and comparing this with SC's disclosed peer group.

The final TSR performance was assessed on 9 March 2023. Following improved share price performance relative to the peer group since the start of 2023, SC ranked above median (i.e., the target for minimum vesting), resulting in an outcome of 14.8 per cent (out of a maximum 33.3 per cent) for TSR, and a total performance outcome of 36.8 per cent, as shown below:

Measure

Weighting

Performance for minimum vesting (25%)

Performance for maximum vesting (100%)

Assessment of achievement

Performance outcome

RoTE in 2022 with CET1 underpin

One-third

8.5%

11.0%

RoTE 8%

 

CET1 passed

0.0%

Relative TSR performance against peer group

One-third

Median

Upper quartile

Above median, below upper quartile

14.8%

Strategic measures

One-third

Details of the performance achieved against the strategic proof points are set out on page 197 of the 2022 annual report.

Improved performance against our strategic priorities

22.0%

Total 2020-22 LTIP performance outcome

36.8%

 

The Remuneration Committee considered carefully the vesting of the 2020-22 LTIP awards, taking account of the factors set out in the DRR and the fact that the TSR measure had been satisfied in part. The Remuneration Committee considers that the values to be delivered continue to remain appropriate, and, for the reasons set out in the DRR, are not a windfall.

Updated single total figure of remuneration for 2022

The projected values disclosed and included in the single total figure of remuneration table for Bill Winters and Andy Halford in the DRR were based on 22 per cent vesting of the 2020-22 LTIP awards, using the three-month average share price to 31 December 2022.

The table below sets out the single total figure of remuneration for 2022 for Bill Winters and Andy Halford, updated with the final performance outcome for the 2020-22 LTIP awards. The single total figures for Bill and Andy represent year-on-year increases of 30 and 27 per cent respectively, reflecting the improved performance achieved for the 2020-22 LTIP awards.

Bill Winters

Andy Halford

£000

2022

2021

2022

2021

Salary

2,418

2,370

1,546

1,515

Pension

245

237

154

152

Benefits

297

165

133

107

Total fixed remuneration

2,960

2,772

1,833

1,774

Annual incentive award

1,499

1,189

945

760

Actual vesting of LTIP award

 

 

Value of vesting awards based on performance

1,540

779

954

498

Value of vesting awards based on share price growth

173

107

Total variable remuneration

3,212

1,968

2,006

1,258

Singe total figure of remuneration

6,172

4,740

3,839

3,032

 

Notes to the single total figure of remuneration table are set out on page 198 of the 2022 annual report.

 

Enquiries to:

Gregg J Powell, Head of Investor Relations +44 (0) 20 7885 5172

Shaun Gamble, Director, Group Media Relations: +44 (0) 20 7885 5934

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKOBQFBKKKND
Date   Source Headline
4th Aug 20226:10 pmRNSHolding(s) in Company
4th Aug 20226:10 pmRNSTransaction in Own Shares
4th Aug 20222:30 pmRNSTotal Voting Rights
3rd Aug 20226:05 pmRNSTransaction in Own Shares
2nd Aug 20226:00 pmRNSTransaction in Own Shares
1st Aug 20226:05 pmRNSChange of Joint-Broker
1st Aug 202211:45 amRNSDirectorate Changes
1st Aug 202211:30 amRNSShare Buy-Back
29th Jul 20222:50 pmRNSPublication of Supplementary Prospectus
29th Jul 20227:00 amRNSSCPLC Half Year Results 2022 - Part 2
29th Jul 20227:00 amRNSSCPLC Half Year Results 2022 - Part 1
29th Jul 20227:00 amRNSHalf Year Report 2022
15th Jul 202210:55 amRNSOverseas Regulatory Announcement
7th Jul 20222:10 pmRNSTotal Voting Rights
28th Jun 202212:50 pmRNSOverseas Regulatory Announcement
27th Jun 20223:00 pmRNSPublication of Final Terms
16th Jun 202211:50 amRNSPublication of a Prospectus
15th Jun 20225:00 pmRNSHolding(s) in Company
14th Jun 20221:00 pmRNSHolding(s) in Company
13th Jun 20228:00 amRNSFinancial Markets Investor Event
10th Jun 20227:30 amRNSSCPLC publishes resolvability disclosure
9th Jun 20225:35 pmRNSHolding(s) in Company
7th Jun 20225:00 pmRNSTotal Voting Rights
6th Jun 20225:10 pmRNSBlock listing Interim Review
6th Jun 20223:30 pmRNSHolding(s) in Company
31st May 20226:00 pmRNSDirector/PDMR Shareholding
25th May 202210:45 amRNSDirector Declaration
19th May 20226:19 pmRNSTransaction in Own Shares
18th May 20226:05 pmRNSTransaction in Own Shares
17th May 20226:05 pmRNSTransaction in Own Shares
16th May 20226:20 pmRNSDirector/PDMR Shareholding
16th May 20225:37 pmRNSTransaction in Own Shares
13th May 20226:00 pmRNSTransaction in Own Shares
12th May 20225:50 pmRNSTransaction in Own Shares
11th May 20226:15 pmRNSTransaction in Own Shares
10th May 20225:45 pmRNSDirector/PDMR Shareholding
10th May 20225:29 pmRNSTransaction in Own Shares
9th May 20225:45 pmRNSTransaction in Own Shares
6th May 20226:00 pmRNSTransaction in Own Shares
6th May 20225:40 pmRNSTotal Voting Rights
6th May 20229:00 amRNSDirector Declaration
5th May 20226:05 pmRNSTransaction in Own Shares
4th May 20226:25 pmRNSResult of AGM
29th Apr 20224:40 pmRNSPublication of Supplementary Prospectus
29th Apr 20221:15 pmRNSDirectorate Change
28th Apr 20226:00 pmRNSTransaction in Own Shares
28th Apr 20224:10 pmRNS1Q 2022 Pillar 3 Disclosures
28th Apr 20227:00 amRNSFirst Quarter 2022 Results
27th Apr 20225:55 pmRNSTransaction in Own Shares
26th Apr 20226:10 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.